Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-06

FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clobetasol Propionate (generic) (clobetasol propionate)

Snippet

SUPPL AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)